Patents by Inventor Patrick J. Koestler

Patrick J. Koestler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12686675
    Abstract: The present embodiments are directed, in part, to processes and compositions that can, for example, be used in the preparation compounds of Formula (I), or a pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: October 26, 2023
    Date of Patent: July 21, 2026
    Assignee: Trevena, Inc.
    Inventors: Brian H. Heasley, Jennifer Wilent, Patrick J. Koestler
  • Patent number: 12679825
    Abstract: The present disclosure provides novel crystalline forms of a compound that acts as a ?-opioid effector, processes for preparing and precipitating amorphous and crystalline forms of the compound, and uses thereof.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: July 14, 2026
    Assignee: Trevena, Inc.
    Inventors: Victoria A. Pollard, Laura E.N. Allan, Hayley A. Reece, Patrick J. Koestler
  • Publication number: 20240317728
    Abstract: The present embodiments are directed, in part, to processes and compositions that can, for example, be used in the preparation compounds of Formula (I), or a pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 26, 2023
    Publication date: September 26, 2024
    Inventors: Brian H. Heasley, Jennifer Wilent, Patrick J. Koestler
  • Patent number: 11884655
    Abstract: The present embodiments are directed, in part, to processes and compositions that can, for example, be used in the preparation compounds of Formula (I), or a pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: January 30, 2024
    Assignee: Trevena, Inc.
    Inventors: Brian H. Heasley, Jennifer Wilent, Patrick J. Koestler
  • Publication number: 20230391749
    Abstract: The present disclosure provides novel crystalline forms of a compound that acts as a ?-opioid effector, processes for preparing and precipitating amorphous and crystalline forms of the compound, and uses thereof.
    Type: Application
    Filed: October 27, 2021
    Publication date: December 7, 2023
    Inventors: Victoria A. Pollard, Laura E.N. Allan, Hayley A. Reece, Patrick J. Koestler
  • Publication number: 20210147402
    Abstract: The present embodiments are directed, in part, to processes and compositions that can, for example, be used in the preparation compounds of Formula (I), or a pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: November 17, 2020
    Publication date: May 20, 2021
    Inventors: Brian H. Heasley, Jennifer Wilent, Patrick J. Koestler